Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-31

FDA Approved: LANTHANUM CARBONATE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lanthanum carbonate from Cipla USA Inc., approving an update to the product's labeling for the generic drug. This ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LANTHANUM CARBONATE (lanthanum carbonate)

Snippet

SUPPL AP for LANTHANUM CARBONATE (LANTHANUM CARBONATE)